Celcuity outlines VIKTORIA-2 expansion while targeting July 17 FDA decision for gedatolisib
Celcuity Inc. Common Stock · SERVICES-MEDICAL LABORATORIES · Now $122.96
-4.0% in 1d after detection
Post-detection moves
1h
—
1d
-4.0%
3d
+1.9%
7d
-2.7%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS